Importantly, the authors found that STING silencing was associated with LKB1 loss also in KRAS WT lung cancers, and was especially robust when combined with elevated DNMT1 levels, suggesting that this mechanism is not purely limited to the KL cellular state. The gene discussed is STING1; the disease is lung carcinoma.